삼성바이오로직스: directors' dealings · South Korea · DART (FSS)

Explore the full directors' dealings record of 삼성바이오로직스, a listed issuer based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Healthcare sector, 삼성바이오로직스 has logged 2 reports. Market capitalisation: €64,159.3bn. The latest transaction was filed on 12 March 2026 — Other. Among the most active insiders: 컨두잇. Every trade is openly available.